KL

Kishan Lal

Active Director Director DIN 07010431
DIN 07010431 First appointment Dec 2014 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2014
Shareholding value •••• Premium profile

About Kishan Lal

Data last updated:

Kishan Lal is a Director at Avaa Medical And Research Centre Private Limited (since 2014). The company operates in Healthcare. Avaa Medical And Research Centre Private Limited reported revenue of ₹48.9 Lakh (FY 2025).

DIN 07010431
Primary Designation Director
Industry Healthcare
First Appointment 10 Dec 2014
Oldest Company Age 11 yrs
Largest company Avaa Medical And Research Centre Private Limited · ₹48.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Dec 20142014₹48.9 Lakh (FY 2025)Active

Board colleagues of Kishan Lal

Directorship timeline

Open interactive timeline →
Avaa Medical And Research Centre Private Limited
Premium access

Shareholding and investment profile for Kishan Lal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kishan Lal

Kishan Lal currently holds 1 directorship: Avaa Medical And Research Centre Private Limited (Director, since 10 Dec 2014, revenue ₹48.9 Lakh (FY 2025)).

Kishan Lal was first appointed on 10 Dec 2014 as Director at Avaa Medical And Research Centre Private Limited.

The current boards of Kishan Lal's companies include Drmukesh Kumar Rai (Avaa Medical And Research Centre Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available